AKUMS DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,118 Cr | ₹4,178 Cr | ₹3,655 Cr | ₹3,672 Cr | ₹2,723 Cr |
What is the latest Revenue of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹4,118 Cr |
| Mar2024 | ₹4,178 Cr |
| Mar2023 | ₹3,655 Cr |
| Mar2022 | ₹3,672 Cr |
| Mar2021 | ₹2,723 Cr |
How is Revenue of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,118 Cr | -1.44 | |
| Mar2024 | ₹4,178 Cr | 14.32 | |
| Mar2023 | ₹3,655 Cr | -0.46 | |
| Mar2022 | ₹3,672 Cr | 34.87 | |
| Mar2021 | ₹2,723 Cr | - | |
Compare Revenue of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹6,984.6 Cr | -0.7% | 5% | -28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | -0.7% |
5% |
-28.2% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses